Ensuring Workplace Safety with Drug Screening Tests: A Commitment from AMA Prevention
Share
Workplace safety and health are top priorities for any responsible company. French legislation, notably Article L4122-1 of the Labor Code, requires employers to take all necessary measures to ensure a safe working environment. A key part of this responsibility includes preventing the use of psychoactive substances, such as drugs, in the workplace. At AMA Prevention, we are committed to helping companies comply with this obligation through our reliable and effective drug screening tests.
Why Drug Screening Tests Are Essential
Drug screening tests are indispensable tools for ensuring workplace safety. Their use allows to:
- Prevent workplace accidents: Employees under the influence of drugs can endanger their own safety as well as that of their colleagues. The use of psychoactive substances can cause impairments in motor and cognitive abilities, such as slowed reflexes, loss of coordination, and poor judgment. These effects significantly increase the risk of accidents, especially in work environments where machinery operation, handling hazardous substances, or performing complex tasks are common. By implementing regular screening tests, employers can detect and prevent drug use, thereby ensuring a safer work environment for everyone.
- Maintain a productive work environment: Drug use can impair employees’ cognitive and physical abilities, affecting their performance and productivity. Psychoactive substances may cause concentration problems, memory issues, increased fatigue, and unpredictable behavior. These effects harm not only the individual using drugs but also the entire team, potentially causing delays, errors, and an overall decrease in work efficiency. By using screening tests, companies can identify employees under the influence and take appropriate measures to maintain a productive and harmonious workplace.
- Comply with legislation: In accordance with Article L4122-1 of the Labor Code, companies must ensure that no employee works under the influence of psychoactive substances. Failure to comply with this regulation can lead to sanctions for the employer, as well as legal consequences in case of accidents related to drug use. By implementing drug screening policies, employers demonstrate their commitment to respecting the law and protecting the health and safety of their employees. This also helps reduce the risk of litigation and maintain the company’s reputation as a responsible employer concerned with the well-being of its workforce.
Our Range of Saliva Drug Screening Tests
At AMA Prevention, we offer a comprehensive range of drug screening tests tailored to the needs of companies:
The DRUGDIAG Saliva Range
The DRUGDIAG Saliva range offers different types of tests capable of detecting up to 6 drugs:
- DRUGDIAG Saliva THC (Cannabis)
- DRUGDIAG Saliva 5+: THC, AMP, OPI, COC, MET/MDMA
- DRUGDIAG Saliva 6+: THC, AMP, OPI, COC, BZO, MET/MDMA
- DRUGDIAG Saliva Innovation 5+: THC, AMP, OPI, COC, MET/MDMA
TODA Pharma solutions are manufactured in France in Strasbourg (67), certified ISO 13485, and undergo strict quality controls to ensure optimal performance.
Conclusion
Investing in drug screening tests is a proactive approach for any company concerned about the health and safety of its employees. At AMA Prevention, we provide reliable and accurate screening solutions, made in France, to help companies meet their legal obligations and maintain a safe and productive work environment. To learn more about our products and how they can meet your specific needs, feel free to visit our website or contact our sales department.
Stay informed and protected with AMA Prévention, your trusted partner for workplace safety.
B-SAFE Scientific Validation
The B-SAFE project, a drug detector pen for drinks, is validated and supported by Professor Jean-Claude Alvarez, toxicologist, professor of pharmacology-toxicology, and director of the toxicology laboratory at CHU Raymond-Poincaré/AP-HP in Garches.
A leading authority in toxicology, he is associated with key reference work conducted in France on psychoactive substances and chemical submission, within a national ecosystem also brought into public debate by voices such as Sandrine Josso and Caroline Darian.
This validation strengthens B-SAFE’s technological positioning and the accuracy of its detection for preventing drugs in drinks. Discover the B-SAFE product sheet.